Evidence map›Paper›PMID 32522006›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2020

ADAM (a Disintegrin and Metalloproteinase) 15 Deficiency Exacerbates Ang II (Angiotensin II)-Induced Aortic Remodeling Leading to Abdominal Aortic Aneurysm.

Sayantan Jana, Michael Chute, Mei Hu, Gerrit Winkelaar, Caroline A Owen, Gavin Y Oudit, Zamaneh Kassiri

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Adamalysins in COVID-19 - Potential mechanisms behind exacerbating the disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Identifying novel mechanisms of abdominal aortic aneurysmFrontiers in cardiovascular medicine · 2022
    Article
  20. Contribution of ADAM17 and related ADAMs in cardiovascular diseases.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sayantan JanaFrom the Department of Physiology, Cardiovascular Research Center (S.J., M.C., M.H., G.Y.O., Z.K.), University of Alberta, Edmonton, Canada.
Michael ChuteFrom the Department of Physiology, Cardiovascular Research Center (S.J., M.C., M.H., G.Y.O., Z.K.), University of Alberta, Edmonton, Canada.
Mei HuFrom the Department of Physiology, Cardiovascular Research Center (S.J., M.C., M.H., G.Y.O., Z.K.), University of Alberta, Edmonton, Canada.
Gerrit WinkelaarDivision of Vascular Surgery, University of Alberta and Northern Alberta Vascular Center, Grey Nuns Hospital, Edmonton, Canada (G.W.).
Caroline A OwenBrigham and Women's Hospital/Harvard Medical School, Boston, MA (C.A.O.).
Gavin Y OuditFrom the Department of Physiology, Cardiovascular Research Center (S.J., M.C., M.H., G.Y.O., Z.K.), University of Alberta, Edmonton, Canada.
Zamaneh KassiriFrom the Department of Physiology, Cardiovascular Research Center (S.J., M.C., M.H., G.Y.O., Z.K.), University of Alberta, Edmonton, Canada.
University of Alberta · CAGrey Nuns Community Hospital · CA

Funding

CIHR
6 · The paper itself

Abstract

objectiveADAM (a disintegrin and metalloproteinase) 15-a membrane-bound metalloprotease from the ADAM (disintegrin and metalloproteinase) family-has been linked to endothelial permeability, inflammation, and metastasis. However, its function in aortic aneurysm has not been explored. We aimed to determine the function of ADAM15 in the pathogenesis of aortic remodeling and aneurysm formation. Approach and Results: Male

conclusionsThis study is the first to demonstrate a key role for ADAM15 in abdominal aortic aneurysm through regulating the SMC function, thereby placing ADAM15 in a critical position as a potential therapeutic target for abdominal aortic aneurysm.

Indexed as

ADAM ProteinsAngiotensin IIAnimalsAorta, AbdominalAortic Aneurysm, AbdominalCell ProliferationCells, CulturedHumansInflammationMaleMembrane ProteinsMiceMuscle, Smooth, VascularMyocytes, Smooth MuscleThrombospondin 1Vascular RemodelingADAM15 protein, humanAdam15 protein, mouseADAM ProteinsAngiotensin IIMembrane ProteinsThrombospondin 1angiotensin IIdisintegrinselastinmyocytes, smooth musclethrombospondins

Identifiers

PMID32522006
PMCPMC7370975
OpenAlexW3033672606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.